Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Epimmune files IND for cancer vaccine

Dec. 10, 2002

Millennium to submit Velcade NDA and MAA filings by early 2003

Dec. 10, 2002

huN901-DM1 enters phase II portion of U.S. SCLC study

Dec. 10, 2002

Corixa and Kirin collaborate on WT1 cancer vaccine development

Dec. 9, 2002

Apoptosis-inducing hydrazones as novel antitumor agents

Dec. 9, 2002

Vertex researchers describe novel series of ERK inhibitors

Dec. 9, 2002

CeMines and CePeP enter pilot program for peptide-based cancer drugs

Dec. 9, 2002

No cytotoxic effect reported for seocalcitol monotherapy in pancreatic cancer

Dec. 9, 2002

High response rate found for temozolomide plus celecoxib in recurrent malignant glioma

Dec. 9, 2002

Allos to begin rolling NDA submission for RSR-13

Dec. 5, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...